Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Large retrospective analysis of 153 PCL patients using new definition of ≥ 5% circulating plasma cells finds secondary PCL associated with a worse prognosis, with median OS of 3.2 months vs. 36.6 months for primary PCL.”
Authors: Shagun Singh, Supriya Peshin, Betsy Wertheim, Ashley Larsen, Iloabueke Chineke, Douglas Sborov, Damian Green, Michaela Liedtke, Marie Okoniewski, Mohammed Wazir, Omar Nadeem, Levanto Schachter, Dominique DeGraaff, Victoria Vardell, David Coffey, Krisstina Gowin.
More posts featuring Robert Orlowski.
